My Personal Therapeutics

My Personal Therapeutics is a London based biotechnology company offering ultra-personalised cancer therapeutics based on technology pioneered at The Mount Sinai School of Medicine, New York. The Personal Discovery Process (PDP) was developed to effectively address the finding that real world tumours are made resistant to single-drug treatments. We engineer the genetic complexity of a patient’s tumour network into an army of 400,000 fruit fly “avatars.” Using robotics, we evaluate up to 1,800 FDA-approved drugs including non-cancer drugs, to identify precise drug combinations that work optimally on a patient’s specific tumour, increasing the prospects of an efficient treatment while also reducing toxicity and side effects.